AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2022
Feb 9, 2022
34519_dirs_2022-02-09_b5f46fa6-8385-40ca-aea5-d539b60b7c65.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2022-01-31
Reporting Person: Brockmann Bobbi Jo (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-01-31 | Incentive Stock Options (Right to buy) | $8.1500 | A | 18000.0000 | Acquired | 2032-02-09 | Common Stock (18000.0000) | Direct |
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23